Exidavnemab (Biosimilar Reference Antibody) (SNCA)
Exidavnemab (Biosimilar Reference Antibody) (SNCA)
Exidavnemab (Biosimilar Reference Antibody) (SNCA)-RA0696-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.
ELISA plate pre-coated Antigen protein, can bind Exidavnemab (Biosimilar Reference Antibody) (SNCA)-RA0696 in a linear range of 3.91-125 ng/mL.
Exidavnemab (Biosimilar Reference Antibody) (SNCA)

Catalog: 

RA0696

Target

SNCA

Isotype

IgG4 - kappa

Applications

ELISA;FC;Functional Assays;IF

Reactivities

Human

Size ($):

100 μg-50;1 mg-210;5 mg-500;10 mg-800;25 mg-1750;50 mg-3000;100 mg-4600

Data Sheet

Material Safety Data Sheet

Certificate of Analysis

Product Description

Exidavnemab is an investigational monoclonal antibody being developed as a novel disease-modifying treatment for neuronal synucleinopathies, specifically Multiple System Atrophy (MSA) and Parkinson's disease (PD). It functions as a targeted immunotherapeutic agent designed to engage with and promote the clearance of pathological alpha-synuclein (α-synuclein) aggregates, a hallmark proteinopathy central to these neurodegenerative diseases. By binding to specific forms of misfolded α-synuclein, exidavnemab aims to facilitate their removal, potentially slowing or halting the underlying neurodegenerative process, rather than merely alleviating symptoms.

Synonyms

PR-1808164, ABBV-0805, BAN-0805, PD-0805

CAS

2438229-02-6

Isotype

IgG4 - kappa

Host

Chimeric and/or humanised

Target

SNCA

Reactivity

Human

Expression System

CHO

Applications

ELISA, FC, Functional Assays, IF; Recommended dilution: FC, IF:1:200

Purity

>98% by SDS-PAGE

Concentration

Bottled at the concentration indicated on the vial.

Buffer

0.01M PBS, pH 7.4, contains no stabilizers or preservatives.

Endotoxin

<1.0 EU/mg as determined by LAL method

Conjugation

Non-conjugated

Formulation

Liquid or Lyophilized powder Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.

Storage

store at -20°C or -80°C. Avoid repeated freeze.

Type

Antibody

Purposes

For research use only

References 1

Exidavnemab binds to aggregated α-synuclein in human brains affected by α-synucleinopathies

References 2

Safety, Tolerability, and Pharmacokinetics of Single Doses of Exidavnemab (BAN0805), an Anti-α-Synuclein Antibody, in Healthy Western, Caucasian, Japanese, and Han Chinese Adults

References 3

References 4

References 5

Product Citations 1

Product Citations 2

https://pubmed.ncbi.nlm.nih.gov/41198458/
https://pubmed.ncbi.nlm.nih.gov/39105497/
https://www.oursmab.com/News/Parkinson-s-disease-treatment-target-SNCA.html

Target Description

Synonyms

synuclein alpha, PARK1, PARK4, "Parkinson disease (autosomal dominant, Lewy body) 4", "synuclein, alpha (non A4 component of amyloid precursor)"

Biology Area

Neuroscience

Function

Pathological forms of alpha-synuclein (α-synuclein), a presynaptic neuronal protein. In its native state, α-synuclein is soluble and functional. However, in synucleinopathies like MSA and PD, it misfolds and aggregates into toxic oligomers and insoluble fibrils, which form intraneuronal inclusions known as Lewy bodies (in PD) and glial cytoplasmic inclusions (in MSA). These aggregates are believed to propagate through the brain in a prion-like manner, driving neurodegeneration and disease progression.

Additional Articles 1

Parkinson-s-disease-treatment-target-SNCA

Additional Articles 2

Related Products

Catalog: 

RA0696

Target:

CEACAM-1/CD66a

Isotype:

IgG4 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0696

Target:

CD274/PDL1/B7H1

Isotype:

IgG - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0696

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0696

Target:

IL6R/CD126

Isotype:

IgG1 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0696

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0696

Target:

IL7R/CD127

Isotype:

IgG1 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0696

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0696

Target:

IL7R/CD127

Isotype:

IgG4 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0696

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0696

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Contact Us

Send your request

Talk to us 

Get a quotation, discuss your requirement, receive advises from our antibody experts without obligation.